Skip to main content

M 25 (Aspirin and Extended-Release Dipyridamole 25 mg / 200 mg)

Pill with imprint M 25 is Red & White, Capsule-shape and has been identified as Aspirin and Extended-Release Dipyridamole 25 mg / 200 mg. It is supplied by Micro Labs Limited.

Aspirin/dipyridamole is used in the treatment of ischemic stroke, prophylaxis and belongs to the drug class platelet aggregation inhibitors. There is positive evidence of human fetal risk during pregnancy. Aspirin/dipyridamole 25 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 25

Aspirin and Extended-Release Dipyridamole

Imprint
M 25
Strength
25 mg / 200 mg
Color
Red & White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Platelet aggregation inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Micro Labs Limited
National Drug Code (NDC)
42571-0274
Inactive Ingredients
caprylic/capric mono/diglycerides, D&C Yellow No. 10, ferric oxide red, ferric oxide yellow, FD&C Blue No. 1, glyceryl monostearate, hypromellose 2910 (6 mPa.s), methacrylic acid - methyl methacrylate copolymer (1:1), microcrystalline cellulose, povidone, polyethylene glycol, sodium lauryl sulfate, talc, tartaric acid, titanium dioxide, triacetin, triethyl citrate, gelatin, shellac, propylene glycol, ferrosoferric oxide, potassium hydroxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "M 25"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.